Literature DB >> 29272791

Disrupted functional connectivity of the amygdala is associated with depressive mood in type 2 diabetes patients.

Wenqing Xia1, Yong Luo1, Yu-Chen Chen2, Danfeng Zhang1, Fan Bo2, Peihua Zhou1, Huiyou Chen2, Fang Wang2, Xindao Yin3, Jianhua Ma4.   

Abstract

BACKGROUND: Type 2 diabetes mellitus (T2DM) and mood disorders share pathophysiological commonalities in the central nervous system. The purpose of this study was to investigate the alterations in amygdala-based emotional processing circuits in T2DM patients with depressive mood using resting-state functional magnetic resonance imaging (rs-fMRI).
METHODS: T2DM patients with depressive mood (n = 25), T2DM patients without depressive mood (n = 28) and matched healthy controls (n = 25) underwent neuropsychological testing and rs-fMRI scanning. A seed-based correlation analysis was conducted to reveal the altered functional connectivity (FC) of the amygdala. The bilateral amygdala FC was compared among the three groups. Pearson correlation analyses were performed in a voxel-wise manner to investigate the relationship between amygdala FC and the clinical characteristics.
RESULTS: The depressed T2DM patients exhibited the worst performance on the neuropsychological tests among the three groups. Compared to the non-depressed T2DM patients, the depressed T2DM patients showed decreased amygdala FC in the cingulate cortex, inferior frontal gyrus, fusiform gyrus, and precentral gyrus. Moreover, the amygdala FC in the cingulate cortex was associated with the Self-Rating Depression Scale (SDS) score in the T2DM patients. LIMITATIONS: Cross-sectional design.
CONCLUSIONS: The current study revealed the cognitive changes and alterations in the amygdala-cingulate functional disconnections in T2DM patients with depressive mood, which will advance the understanding of the neural mechanisms underlying depression in T2DM patients.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amygdala; Depression; Functional connectivity; Resting-state fMRI; Type 2 diabetes mellitus

Mesh:

Year:  2017        PMID: 29272791     DOI: 10.1016/j.jad.2017.12.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

Review 1.  Executive Function and Diabetes: A Clinical Neuropsychology Perspective.

Authors:  Qian Zhao; Yonggang Zhang; Xiaoyang Liao; Weiwen Wang
Journal:  Front Psychol       Date:  2020-08-20

2.  Altered White Matter Microstructures in Type 2 Diabetes Mellitus: A Coordinate-Based Meta-Analysis of Diffusion Tensor Imaging Studies.

Authors:  Cong Zhou; Jie Li; Man Dong; Liangliang Ping; Hao Lin; Yuxin Wang; Shuting Wang; Shuo Gao; Ge Yu; Yuqi Cheng; Xiufeng Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-03       Impact factor: 5.555

3.  Altered functional connectivity of brain regions based on a meta-analysis in patients with T2DM: A resting-state fMRI study.

Authors:  Dongsheng Zhang; Jie Gao; Xuejiao Yan; Min Tang; Xia Zhe; Miao Cheng; Weibo Chen; Xiaoling Zhang
Journal:  Brain Behav       Date:  2020-06-18       Impact factor: 2.708

4.  Abnormal functional connectivity of the amygdala is associated with depressive symptoms in patients with multiple system atrophy.

Authors:  Bin Zhao; Hu Liu; Huanhuan Li; Xiuli Shang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-11-15       Impact factor: 2.570

5.  Differences in brain activity between normal and diabetic rats under isoflurane anesthesia: a resting-state functional MRI study.

Authors:  Sheng-Min Huang; Chun-Yi Wu; Yu-Hsin Lin; Hsin-Hua Hsieh; Hui-Chieh Yang; Shao-Chieh Chiu; Shin-Lei Peng
Journal:  BMC Med Imaging       Date:  2022-08-04       Impact factor: 2.795

6.  Altered Functional Connectivity of Insular Subregions in Type 2 Diabetes Mellitus.

Authors:  Dongsheng Zhang; Man Wang; Jie Gao; Yang Huang; Fei Qi; Yumeng Lei; Kai Ai; Xuejiao Yan; Miao Cheng; Yu Su; Xiaoyan Lei; Xiaoling Zhang
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.